Overview Corticosteroid Dosage for Crohn's Disease Flare Status: Terminated Trial end date: 2016-12-19 Target enrollment: Participant gender: Summary Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares. Phase: Phase 4 Details Lead Sponsor: Yale UniversityTreatments: MethylprednisoloneMethylprednisolone acetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphatePrednisone